Clinical management of ESBL-producing Enterobacteriaceae: The insidious role of fluoroquinolones

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 7, 2012, Pages 1517-1522

  Rossotti, R ^a,b   Orani, A ^a  

^a A MANZONI HOSPITAL   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; QUINOLONE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HOSPITAL ADMISSION; HUMAN; INDIVIDUALIZATION; INTERNAL MEDICINE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL RECORD REVIEW; MICROBIOLOGICAL EXAMINATION; MULTIVARIATE ANALYSIS; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS; AGED; DRUG THERAPY; ENTEROBACTERIACEAE; ENZYMOLOGY; HEALTH SERVICES RESEARCH; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; SECRETION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG THERAPY; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FLUOROQUINOLONES; HEALTH SERVICES RESEARCH; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 84865577118     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1472-y     Document Type: Article

References (18)

1. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11(6):315-317
2. Livermore DM (1995) ß-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8:557-584
3. Coque TM, Baquero F, Canton R (2008) Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 13 (47):pii19044
4. Luzzaro F, Mezzatesta M, Mugnaioli C, Perilli M, Stefani S, Amicosante G, Rossolini GM, Toniolo A (2006) Trends in production of extended-spectrum ß-lactamases among Enterobacteria on medical interest: Report of the second Italian nationwide survey. J Clin Microbiol 44(5):1659-1664
5. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum ß-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32:1162-1171
6. Tsering DC, Das S, Adhiakari L, Pal R, Singh TS (2009) Extended spectrum beta-lactamase detection in gram-negative bacilli of nosocomial origin. J Glob Infect Dis 1(2):87-92
7. Koksal F, Ak K, Kucukbasmaci O, Samasti M (2009) Prevalence and antimicrobial resistance patterns of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital. Chemotherapy 55(4):293-297
8. Jacoby GA, Chow N, Waites KB (2003) Prevalence of plasmidmediated quinolone resistance. Antimicrob Agents Chemother 47:559-562
9. Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P (2005) Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 49:71-76
10. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO (2001) Epidemiological investigation of fluoroquinolones resistance in infections due to extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 33(8):1288-1294
11. Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush K (1994) Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: Identification of the extendedspectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing betalactamases in a single isolate. Antimicrob Agents Chemother 38:761-766
12. Chanawong A, M'Zali FH, Heritage J, Xiong JH, Hawkey PM (2002) Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 46(3):630-637
13. Thomson KS (2010) Extended-spectrum-ß-lactamase, AmpC, and carbapenemase issues. J Clin Microbiol 48(4):1019-1025
14. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I (2005) Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum ß-lactamase-producing Enterobacteriaceae. Arch Intern Med 165:1375-1380
15. http://www.federalreserve.gov/release/g5a
16. Tumbarello M, Sali M, Trecarichi EM, Leone F, Rossi M, Fiori B, De Pascale G, D'Inzeo T, Sanguinetti M, Fadda G, Cauda R, Spanu T (2008) Bloodstream infections caused by extended-spectrum-ß-lactamase-producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother 52(9):3244-3252
17. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D'Inzeo T, Fadda G, Cauda R, Spanu T (2007) Predictors of morality in patients with bloodstream infections caused by extended-spectrum- ß-lactamase-producing Enterobacteriaceae: Importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51 (6):1987-1994
18. Tumbarello M, Spanu T, Di Bidino R, Marchetti M, Ruggeri M, Trecarichi EM, De Pascale G, Proli EM, Cauda R, Cicchetti A, Fadda G (2010) Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-ß-lactamase production and inadequate initial therapy. Antimicrob Agents Chemother 54(10):4085-4091